Shockwave Medical Inc. Stock News

We have narrowed our search to five Medical Instruments stocks with strong potential for 2024. These are: AORT, TMDX, DXCM, SWAV, EW.

ShockWave Medical (SWAV) continues to benefit from solid R&D endeavors and its commitment to clinical studies.

Does Shockwave Medical (SWAV) have what it takes to be a top stock pick for momentum investors? Let's find out.

Turnaround play General Motors and hot energy drink maker Celsius Holdings lead this weekend's watchlist.

Shockwave Medical's (SWAV) fourth-quarter results reflect robust revenue growth and gross margin expansion on the back of strong demand and new launches.

Shockwave Medical, Inc. (SWAV) Q4 2023 Earnings Call Transcript

Shockwave Medical (SWAV) came out with quarterly earnings of $1.16 per share, beating the Zacks Consensus Estimate of $0.92 per share. This compares to earnings of $3.71 per share a year ago.

Shockwave Medical is a med-tech company that utilizes Intravascular Lithotripsy technology to treat cardiovascular diseases. The company has a significant market presence and stands to capture a signi

Shockwave Medical is a pioneer in intravascular lithotripsy and has recently experienced a reset valuation due to temporary factors. The company has shown strong revenue growth in 2023, but is facing

ShockWave Medical (SWAV) continues to benefit from solid R&D endeavors and its commitment to clinical studies.

When it comes to biotech stocks, I usually like to take a “Goldilocks” approach. This involves investing in biotech companies that have one or more promising drugs in mid-to-late stage clinical tr

Stock markets were broadly higher on Tuesday. However, Shockwave Medical shares fell despite strong results from the medical device maker in the third quarter of 2023.

Shockwave Medical's (SWAV) third-quarter results reflect robust revenue growth and gross margin expansion on the back of strong demand and new launches.

Shockwave Medical, Inc. (NASDAQ:SWAV ) Q3 2023 Earnings Conference Call November 6, 2023 4:30 PM ET Company Participants Debbie Kaster - Vice President, Investor Relations Doug Godshall - President an

Shockwave Medical (SWAV) came out with quarterly earnings of $0.92 per share, beating the Zacks Consensus Estimate of $0.81 per share. This compares to earnings of $0.92 per share a year ago.